atai Life Sciences Announces First Subject Dosed in Phase 1 Trial of Buccal and IV VLS-01, a Synthetic Form of DMT PressReach · Oct 5, 2022
Seelos Therapeutics to Participate in the Guggenheim Nantucket Therapeutics Conference PressReach · Sep 9, 2022
Red Light Holland Announces Live Investor Q&A Session at 2:00 PM (EST) on Thursday, September 8, 2022 PressReach · Sep 2, 2022
MindMed Announces First Patient Dosed in Phase 2b Trial of MM-120 in Generalized Anxiety Disorder PressReach · Aug 25, 2022
Seelos Therapeutics Receives a Research and Development Grant from The Michael J. Fox Foundation for Parkinson's Research for SLS-004 PressReach · Aug 24, 2022
Healthy Extracts Reports Record Second Quarter 2022, Net Revenue up 93% with Strong Subscription-Based Revenue Growth PressReach · Aug 15, 2022
Red Light Holland to Acquire Two Wellness Shops in the Netherlands: SmartShop Utrecht and SmartShop OSS PressReach · Aug 9, 2022
MindMed to Participate in the Canaccord Genuity 42nd Annual Growth Conference PressReach · Aug 3, 2022
